Tildiem Retard 120 mg Prolonged Release Tablets
- Licence status
- Withdrawn: 04/01/2016
- Active substances
- Diltiazem hydrochloride
- Dosage Form
- Tablet
- Licence number
- PA0540/161/005
- Licence holder
- Sanofi-Aventis Ireland Limited T/A SANOFI
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- C08DB Benzothiazepine derivatives, C08DB01 diltiazem
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 12/02/2010